SCHEMBL7126540

SCHEMBL7126540

CN(C)/C=C1\C(=O)Cc2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
ALDH1A1 P00352 9/20 0.56
MAPT P10636 4/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
HTT P42858 1/20 0.56
HIF1A Q16665 1/20 0.56
BCHE P06276 1/20 0.50
CES1 P23141 1/20 0.50
MAP1LC3B Q9GZQ8 4/20 0.46
MAOA P21397 2/20 0.44
HSD17B10 Q99714 4/20 0.44
MAOB P27338 1/20 0.41
ALOX15 P16050 1/20 0.40
HPGD P15428 1/20 0.40
SLC6A2 P23975 2/20 0.39
SLC22A1 O15245 1/20 0.39
CACNA1F O60840 1/20 0.39
NTRK1 P04629 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7126546 1.00 KDM4E (0.60) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL7344787 0.84 ALDH1A1 (0.55) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL3567070 0.76 CA12 (0.59) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL11070836 0.76 MAOA (0.56) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL3567074 0.76 CA12 (0.59) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL25272582 0.76 MAOA (0.56) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL31339132 0.76 MAOA (0.56) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL2186787 0.75 KDM4E (1.00) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL2186785 0.75 KDM4E (1.00) KDM4EMEN1KMT2AALDH1A1MAPT
SCHEMBL11296118 0.75 KDM4E (1.00) KDM4EMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176454-A1 N-coating heterocyclic compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176454-A1 N-coating heterocyclic compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, GNE, NIT2 KDM4E 2224/4885MEN1 244/4885KMT2A 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.